Mirati Therapeutics
MRTX
#3098
Rank
A$6.17 B
Marketcap
$88.04
Share price
0.00%
Change (1 day)
43.60%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : A$1.46 B

According to Mirati Therapeutics's latest financial reports the company has A$1.46 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$1.59 B-22.35%
2021-12-31A$2.05 B13.69%
2020-12-31A$1.80 B205.54%
2019-12-31A$0.59 B86.76%
2018-12-31A$0.31 B63.63%
2017-12-31A$0.19 B145.48%
2016-12-31A$78.7 M-53.13%
2015-12-31A$0.16 B369.95%
2014-12-31A$35.73 M-48.65%
2013-12-31A$69.58 M95.09%
2012-12-31A$35.67 M29.09%
2011-12-31A$27.63 M280.12%
2010-12-31A$7.26 M-61.01%
2009-12-31A$18.64 M-59.41%
2008-12-31A$45.93 M-34.56%
2007-12-31A$70.18 M-1.96%
2006-12-31A$71.59 M131.98%
2005-12-31A$30.86 M-30.69%
2004-12-31A$44.52 M39.27%
2003-12-31A$31.96 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.57 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.19 M-99.99% Bahamas